Publications 2022

Bramness JG, Hjellvik V, Stubhaug A, Skurtveit S (2022)
Possible opioid-saving effect of cannabis-based medicine using individual-based data from the Norwegian Prescription Database
Basic Clin. Pharmacol. Toxicol., 130 (1), 84-92
DOI 10.1111/bcpt.13660

Moe JS, Bolstad I, Morland JG, Bramness JG (2022)
GABA(A )subunit single nucleotide polymorphisms show sex-specific association to alcohol consumption and mental distress in a Norwegian population-based sample
Psychiatry Res., 307, 114257
DOI 10.1016/j.psychres.2021.114257

Publications 2021

Abebe DS, Lien L, Bramness JG (2021)
Effects of age and gender on the relationship between alcohol use disorder and somatic diseases: a national register study in Norway
BMJ Open, 11 (11), e050608
DOI 10.1136/bmjopen-2021-050608

Bramness JG, Bye EK, Moan IS, Rossow I (2021)
Alcohol Use during the COVID-19 Pandemic: Self-Reported Changes and Motives for Change
Eur. Addict. Res.
DOI 10.1159/000515102

Chalabianloo F, Fadnes LT, Hoiseth G, Ohldieck C, Vold JH, Aas C, Loberg EM, Johansson KA, Bramness JG (2021)
Subjective symptoms and serum methadone concentrations: what should guide dose adjustments in methadone maintenance treatment? A naturalistic cohort study from Norway
Subst/ Abus. Treatment Prev. Pol., 16 (1), 39
DOI 10.1186/s13011-021-00367-w

Drummond C, Hillyard M, Leonhardt M, Wurst F, Dom G, Mann K, Bramness JG (2021)
Comparison of European Clinical Guidelines on the Management of Alcohol Use Disorders
Eur. Addict. Res., 27 (3), 227-235
DOI 10.1159/000512112

Gabrhelik R, Mahic M, Lund IO, Bramness J, Selmer R, Skovlund E, Handal M, Skurtveit S (2021)
Cannabis Use during Pregnancy and Risk of Adverse Birth Outcomes: A Longitudinal Cohort Study
Eur. Addict. Res., 27 (2), 131-141
DOI 10.1159/000510821

Holdo I, Bramness JG, Handal M, Hansen BH, Hjellvik V, Skurtveit S (2021)
Association Between Prescribed Hypnotics in Infants and Toddlers and Later ADHD: A Large Cohort Study from Norway
Child Psychiat. Hum. Dev., 52 (4), 533-543
DOI 10.1007/s10578-020-01039-9

Hoye A, Jacobsen BK, Bramness JG, Nesvag R, Reichborn-Kjennerud T, Heiberg I (2021)
Total and cause-specific mortality in patients with personality disorders: the association between comorbid severe mental illness and substance use disorders
Soc. Psychiatry Psychiatr. Epidemiol., 56 (10), 1809-1819
DOI 10.1007/s00127-021-02055-3

Hoye A, Jacobsen BK, Bramness JG, Nesvag R, Reichborn-Kjennerud T, Heiberg I (2021)
Total and cause-specific mortality in patients with personality disorders: the association between comorbid severe mental illness and substance use disorders (Mar, 10.1007/s00127-021-02055-3, 2021)
Soc. Psychiatry Psychiatr. Epidemiol., 56 (10), 1821
DOI 10.1007/s00127-021-02124-7

Johnson SU, Hoffart A, Tilden T, Toft H, Neupane SP, Lien L, Bramness JG (2021)
Circulating cytokine levels in the treatment of comorbid anxiety disorders
Acta Neuropsychiatr., 33 (2), PII S0924270820000381-71
DOI 10.1017/neu.2020.38

Lien L, Bolstad I, Bramness JG (2021)
Smoking among inpatients in treatment for substance use disorders: prevalence and effect on mental health and quality of life
BMC Psychiatry, 21 (1), 244
DOI 10.1186/s12888-021-03252-9

Oerbeck B, Overgaard KR, Hjellvik V, Lien L, Bramness JG (2021)
The Use of Antidepressants, Antipsychotics, and Stimulants in Youth Residential Care
J. Child Adolesc. Psychopharmacol., 31 (5), 350-357
DOI 10.1089/cap.2020.0123

Pandey S, Bolstad I, Lien L, Bramness JG (2021)
Antisocial Personality Disorder Among Patients in Treatment for Alcohol Use Disorder (AUD): Characteristics and Predictors of Early Relapse or Drop-Out
Subst. Abuse Rehabil., 12, 11-22
DOI 10.2147/SAR.S296526

Rossow I, Bye EK, Moan IS, Kilian C, Bramness JG (2021)
Changes in Alcohol Consumption during the COVID-19 Pandemic-Small Change in Total Consumption, but Increase in Proportion of Heavy Drinkers
Int. J. Environ. Res. Public Health, 18 (8), 4231
DOI 10.3390/ijerph18084231

Stelander LT, Hoye A, Bramness JG, Selbaek G, Lunde LH, Wynn R, Gronli OK (2021)
The changing alcohol drinking patterns among older adults show that women are closing the gender gap in more frequent drinking: the Tromso study, 1994-2016
Subst/ Abus. Treatment Prev. Pol., 16 (1), 45
DOI 10.1186/s13011-021-00376-9

Toft H, Bramness J, Tilden T, Bolstad I, Lien L (2021)
Persistent level of mental distress in PTSD patients is not reflected in cytokine levels 1 year after the treatment
Acta Neuropsychiatr., 33 (5), PII S0924270821000119-260
DOI 10.1017/neu.2021.11

Publications 2020

Andersen N, Bramness JG, Lund IO (2020)
The emerging COVID-19 research: dynamic and regularly updated science maps and analyses
BMC Med. Inform. Decis. Mak., 20 (1), 309
DOI 10.1186/s12911-020-01321-9

Bjorkhaug ST, Neupane SP, Bramness JG, Aanes H, Skar V, Medhus AW, Valeur J (2020)
Plasma cytokine levels in patients with chronic alcohol overconsumption: Relations to gut microbiota markers and clinical correlates
Alcohol, 85, 35-40
DOI 10.1016/j.alcohol.2019.10.002

Bramness JG, Bretteville-Jensen AL (2020)
Cannabis - more dangerous than we thought?
Tidsskr. Nor. Laegeforen., 140 (18), 1845

Bramness JG, Malt UF (2020)
Reduction of antipsychotic drugs
Tidsskr. Nor. Laegeforen., 140 (10), 979

Guldal I, Bramness JG (2020)
Clinical Communication Handbook Oslo: Norwegian Association for General Medicine
Tidsskr. Nor. Laegeforen., 140 (6), 600

Heiberg IH, Nesvag R, Balteskard L, Bramness JG, Hultman CM, Naess O, Reichborn-Kjennerud T, Ystrom E, Jacobsen BK, Hoye A (2020)
Diagnostic tests and treatment procedures performed prior to cardiovascular death in individuals with severe mental illness
Acta Psychiatr. Scand., 141 (5), 439-451
DOI 10.1111/acps.13157

Hjemsaeter AJ, Monsbakken B, Bramness JG, Benth JS, Drake R, Landheim AS, Skeie I (2020)
Levels of mental distress over 18 years after entering treatment for substance use disorders: A longitudinal cohort study
Nord. Stud. Alcohol Drugs, 37 (4), 1455072520947249-364
DOI 10.1177/1455072520947249

Morland J, Bramness JG (2020)
Delta 9-tetrahydrocannabinol (THC) is present in the body between smoking sessions in occasional non-daily cannabis users
Forensic Sci.Int., 309, 110188
DOI 10.1016/j.forsciint.2020.110188

Oerbeck B, Overgaard KR, Hjellvik V, Bramness JG, Hansen BH, Lien L (2020)
The Use of Sleep Medication in Youth Residential Care
J. Child Adolesc. Psychopharmacol., 30 (5), 335-341
DOI 10.1089/cap.2019.0172

Rognli EB, Bramness JG, von Soest T (2020)
Cannabis use in early adulthood is prospectively associated with prescriptions of antipsychotics, mood stabilizers, and antidepressants
Acta Psychiatr. Scand., 141 (2), 149-156
DOI 10.1111/acps.13104

Toft H, Lien L, Neupane SP, Abebe DS, Tilden T, Wampold BE, Bramness JG (2020)
Cytokine concentrations are related to level of mental distress in inpatients not using anti-inflammatory drugs
Acta Neuropsychiatr., 32 (1), PII S092427081900036X-31
DOI 10.1017/neu.2019.36

Wangensteen T, Halsa A, Bramness JG (2020)
Creating meaning to substance use problems: a qualitative study with patients in treatment and their children
J. Subst. Use, 25 (4), 382-386
DOI 10.1080/14659891.2020.1715497

Publications 2019

Bjorkhaug ST, Aanes H, Neupane SP, Bramness JG, Malvik S, Henriksen C, Skar V, Medhus AW, Valeur J (2019)
Characterization of gut microbiota composition and functions in patients with chronic alcohol overconsumption
Gut Microbes, 10 (6), 663-675
DOI 10.1080/19490976.2019.1580097

Bramness JG (2019)
Access to health data is not easy
Tidsskr. Nor. Laegeforen., 139 (8), 690

Bramness JG, Vindenes V (2019)
Medical cannabis
Tidsskr. Nor. Laegeforen., 139 (15), 1437

Bramness JG, von Soest T (2019)
A longitudinal study of cannabis use increasing the use of asthma medication in young Norwegian adults
BMC Pulm. Med., 19, 52
DOI 10.1186/s12890-019-0814-x

Chalabianloo F, Westin AA, Skogvoll E, Bramness JG, Spigset O (2019)
Methadone serum concentrations and influencing factors: A naturalistic observational study
Psychopharmacology, 236 (11), 3159-3167
DOI 10.1007/s00213-019-05277-1

Heiberg IH, Jacobsen BK, Balteskard L, Bramness JG, Naess O, Ystrom E, Reichborn-Kjennerud T, Hultman CM, Nesvag R, Hoye A (2019)
Undiagnosed cardiovascular disease prior to cardiovascular death in individuals with severe mental illness
Acta Psychiatr. Scand., 139 (6), 558-571
DOI 10.1111/acps.13017

Hjemsaeter AJ, Bramness JG, Drake R, Skeie I, Monsbakken B, Benth JS, Landheim AS (2019)
Mortality, cause of death and risk factors in patients with alcohol use disorder alone or poly-substance use disorders: a 19-year prospective cohort study
BMC Psychiatry, 19, 101
DOI 10.1186/s12888-019-2077-8

Shestopal I, Bramness JG (2019)
Effect of Hypnotherapy in Alcohol Use Disorder Compared With Motivational Interviewing: A Randomized Controlled Trial
Addict. Disord. Treat., 18 (3), 169-175
DOI 10.1097/ADT.0000000000000170

Torvik FA, Rosenstrom TH, Gustavson K, Ystrom E, Kendler KS, Bramness JG, Czajkowski N, Reichborn-Kjennerud T (2019)
Explaining the association between anxiety disorders and alcohol use disorder: A twin study
Depress. Anxiety, 36 (6), 522-532
DOI 10.1002/da.22886

Wangensteen T, Bramness JG, Halsa A (2019)
Growing up with parental substance use disorder: The struggle with complex emotions, regulation of contact, and lack of professional support
Child Fam. Soc. Work, 24 (2), 201-208
DOI 10.1111/cfs.12603

Weibell MA, Johannessen JO, Auestad B, Bramness J, Bronnick K, Haahr U, Joa I, Larsen TK, Melle I, Opjordsmoen S, Rund BR, Rossberg JI, Simonsen E, Vaglum P, Stain H, Friis S, Hegelstad WT (2019)
Early Substance Use Cessation Improves Cognition-10 Years Outcome in First-Episode Psychosis Patients
Front. Psychiatry, 10, 495
DOI 10.3389/fpsyt.2019.00495

Publications 2018

Abel KF, Skjaervo I, Ravndal E, Clausen T, Bramness JG (2018)
Perceived Self-Control is Related to Mental Distress in Patients Entering Substance Use Disorder Treatment
Subst. Use Misuse, 53 (9), 1454-1462
DOI 10.1080/10826084.2017.1413114

Bramness JG (2018)
About LSD in the reading room, farmers and proportions
Tidsskr. Nor. Laegeforen., 138 (2), 106

Bramness JG, Dom G, Gual A, Mann K, Wurst FM (2018)
A Survey on the Medical Use of Cannabis in Europe: A Position Paper
Eur. Addict. Res., 24 (4), 201-205
DOI 10.1159/000492757

Gjerden P, Bramness JG, Slordal L (2018)
Kvetiapine is used a lot
Tidsskr. Nor. Laegeforen., 138 (13), 1225-1226

Heiberg IH, Jacobsen BK, Nesvag R, Bramness JG, Reichborn-Kjennerud T, Naess O, Ystrom E, Hultman CM, Hoye A (2018)
Total and cause-specific standardized mortality ratios in patients with schizophrenia and/or substance use disorder
PLoS One, 13 (8), e0202028
DOI 10.1371/journal.pone.0202028

Heldal AT, Skurtveit S, Lobmaier PPK, Vederhus JK, Bramness JG (2018)
Use of drugs for alcoholic disorders in Norway 2004-16
Tidsskr. Nor. Laegeforen., 138 (18), 1710-1715

Morland J, Bramness JG (2018)
Misleading about cannabis and traffic hazard Reply
Tidsskr. Nor. Laegeforen., 138 (2), 112

Nesvag R, Bramness JG, Handal M, Hartz I, Hjellvik V, Skurtveit S (2018)
The incidence, psychiatric co-morbidity and pharmacological treatment of severe mental disorders in children and adolescents
Eur. Psychiat., 49, 16-22
DOI 10.1016/j.eurpsy.2017.12.009

Skurtveit S, Bramness JG, Hjellvik V, Hartz I, Nesvag R, Hauge LJ, Handal M (2018)
Increase in diagnosis of depressive disorders contributes to the increase in antidepressant use in adolescents
Acta Psychiatr. Scand., 137 (5), 413-421
DOI 10.1111/acps.12877

Toft H, Bramness JG, Lien L, Abebe DS, Wampold BE, Tilden T, Hestad K, Neupane SP (2018)
PTSD patients show increasing cytokine levels during treatment despite reduced psychological distress
Neuropsychiatr. Dis. Treat., 14, 2367-2377
DOI 10.2147/NDT.S173659

Toft H, Neupane SP, Bramness JG, Tilden T, Wampold BE, Lien L (2018)
The effect of trauma and alcohol on the relationship between level of cytokines and depression among patients entering psychiatric treatment
BMC Psychiatry, 18, 95
DOI 10.1186/s12888-018-1677-z

Torvik FA, Ystrom E, Gustavson K, Rosenstrom TH, Bramness JG, Gillespie N, Aggen SH, Kendler KS, Reichborn-Kjennerud T (2018)
Diagnostic and genetic overlap of three common mental disorders in structured interviews and health registries
Acta Psychiatr. Scand., 137 (1), 54-64
DOI 10.1111/acps.12829

Wiig EM, Halsa A, Bramness J, Myra SM, Haugland BSM (2018)
Rescue the child or treat the adult? Understandings among professionals in dual treatment of substance-use disorders and parenting
Nord. Stud. Alcohol Drugs, 35 (3), 179-195
DOI 10.1177/1455072518773615

Publications 2017

Abel KF, Ravndal E, Clausen T, Bramness JG (2017)
Attention Deficit Hyperactivity Disorder Symptoms are Common in Patients in Opioid Maintenance Treatment
Eur. Addict. Res., 23 (6), 298-305
DOI 10.1159/000484240

Engh JA, Bramness JG (2017)
Psychosis relapse, medication non-adherence, and cannabis
Lancet Psychiatry, 4 (8), 577-579
DOI 10.1016/S2215-0366(17)30254-7

Gjerden P, Bramness JG, Tvete IF, Slordal L (2017)
The antipsychotic agent quetiapine is increasingly not used as such: dispensed prescriptions in Norway 2004-2015
Eur. J. Clin. Pharmacol., 73 (9), 1173-1179
DOI 10.1007/s00228-017-2281-8

Gjersing L, Jonassen K, Skurtveit S, Bramness J, Clausen T (2017)
Emergency service use is common in the year before death among drug users who die from an overdose
J. Subst. Use, 22 (3), 331-336
DOI 10.1080/14659891.2016.1208778

Kringen MK, Chalabianloo F, Bernard JP, Bramness JG, Molden E, Hoiseth G (2017)
Combined Effect of CYP2B6 Genotype and Other Candidate Genes on a Steady-State Serum Concentration of Methadone in Opioid Maintenance Treatment
Ther. Drug Monit., 39 (5), 550-555
DOI 10.1097/FTD.0000000000000437

Morland J, Bramness JG (2017)
Effects of cannabis last longer than estimated
Tidsskr. Nor. Laegeforen., 137 (20), 1589-1591

Nesvag R, Reichborn-Kjennerud T, Gillespie NA, Knudsen GP, Bramness JG, Kendler KS, Ystrom E (2017)
Genetic and Environmental Contributions to the Association Between Cannabis Use and Psychotic-Like Experiences in Young Adult Twins
Schizophr. Bull., 43 (3), 644-653
DOI 10.1093/schbul/sbw101

Neupane SP, Bramness JG, Lien L (2017)
Comorbid post-traumatic stress disorder in alcohol use disorder: relationships to demography, drinking and neuroimmune profile
BMC Psychiatry, 17, 312
DOI 10.1186/s12888-017-1479-8

Rognli EB, Bramness JG, Skurtveit S, Bukten A (2017)
Substance use and sociodemographic background as risk factors for lifetime psychotic experiences in a non-clinical sample
J. Subst. Abus. Treat., 74, 42-47
DOI 10.1016/j.jsat.2016.12.007

Salvatore S, Bramness JG, Roislien J (2017)
Exploring functional data analysis and wavelet principal component analysis on ecstasy (MDMA) wastewater data (vol 16, 81, 2016)
BMC Med. Res. Methodol., 17, 34
DOI 10.1186/s12874-017-0311-y

Salvatore S, Roislien J, Baz-Lomba JA, Bramness JG (2017)
Assessing prescription drug abuse using functional principal component analysis (FPCA) of wastewater data
Pharmacoepidemiol. Drug Saf., 26 (3), 320-326
DOI 10.1002/pds.4127

Weibell MA, Hegelstad WT, Auestad B, Bramness J, Evensen J, Haahr U, Joa I, Johannessen JO, Larsen TK, Melle I, Opjordsmoen S, Rund BR, Simonsen E, Vaglum P, McGlashan T, McGorry P, Friis S (2017)
The Effect of Substance Use on 10-Year Outcome in First-Episode Psychosis
Schizophr. Bull., 43 (4), 843-851
DOI 10.1093/schbul/sbw179

Publications 2016

Baz-Lomba JA, Salvatore S, Gracia-Lor E, Bade R, Castiglioni S, Castrignano E, Causanilles A, Hernandez F, Kasprzyk-Hordern B, Kinyua J, McCall AK, van Nuijs A, Ort C, Plosz BG, Ramin P, Reid M, Rousis NI, Ryu Y, de Voogt P, Bramness J, Thomas K (2016)
Comparison of pharmaceutical, illicit drug, alcohol, nicotine and caffeine levels in wastewater with sale, seizure and consumption data for 8 European cities
BMC Public Health, 16, 1035
DOI 10.1186/s12889-016-3686-5

Bramness JG (2016)
A better life Stories, experiences and research on the recovery of drug addiction and mental health problems
Tidsskr. Nor. Laegeforen., 136 (20), 1746
DOI 10.4045/tidsskr.16.0767

Bramness JG, Mann K, Wurst FM (2016)
Marketing Status and Perceived Efficacy of Drugs for Supporting Abstinence and Reducing Alcohol Intake in Alcohol Use Disorders: A Survey among European Federation of Addiction Societies in Europe
Eur. Addict. Res., 22 (6), 318-321
DOI 10.1159/000447965

Bramness JG, Rognli EB (2016)
Psychosis induced by amphetamines
Curr. Opin. Psychiatr., 29 (4), 236-241
DOI 10.1097/YCO.0000000000000254

Midgard H, Bramness JG, Skurtveit S, Haukeland JW, Dalgard O (2016)
Hepatitis C Treatment Uptake among Patients Who Have Received Opioid Substitution Treatment: A Population-Based Study
PLoS One, 11 (11), e0166451
DOI 10.1371/journal.pone.0166451

Nesvag R, Hartz I, Bramness JG, Hjellvik V, Handal M, Skurtveit S (2016)
Mental disorder diagnoses among children and adolescents who use antipsychotic drugs
Eur. Neuropsychopharmacol., 26 (9), 1412-1418
DOI 10.1016/j.euroneuro.2016.07.001

Neupane SP, Skulberg A, Skulberg KR, Aass HCD, Bramness JG (2016)
Cytokine Changes following Acute Ethanol Intoxication in Healthy Men: A Crossover Study
Mediat. Inflamm., 2016, 3758590
DOI 10.1155/2016/3758590

Ryu Y, Gracia-Lor E, Bade R, Baz-Lomba JA, Bramness JG, Castiglioni S, Castrignano E, Causanilles A, Covaci A, de Voogt P, Hernandez F, Kasprzyk-Hordern B, Kinyua J, McCall AK, Ort C, Plosz BG, Ramin P, Rousis NI, Reid MJ, Thomas KV (2016)
Increased levels of the oxidative stress biomarker 8-iso-prostaglandin F-2 alpha in wastewater associated with tobacco use
Sci Rep, 6, 39055
DOI 10.1038/srep39055

Salvatore S, Bramness JG, Roislien J (2016)
Exploring functional data analysis and wavelet principal component analysis on ecstasy (MDMA) wastewater data
BMC Med. Res. Methodol., 16, 81
DOI 10.1186/s12874-016-0179-2

Salvatore S, Froslie KF, Roislien J, Zuccato E, Castiglioni S, Bramness JG (2016)
A nuanced picture of illicit drug use in 17 Italian cities through functional principal component analysis of temporal wastewater data
J. Public Health-Heidelberg, 24 (3), 165-174
DOI 10.1007/s10389-016-0717-8

Tjagvad C, Skurtveit S, Bramness JG, Gjersing L, Gossop M, Clausen T (2016)
Misuse of prescription drugs and overdose deaths
J. Subst. Use, 21 (5), 515-520
DOI 10.3109/14659891.2015.1077280

Tveito M, Correll CU, Bramness JG, Engedal K, Lorentzen B, Refsum H, Hoiseth G (2016)
Correlates of major medication side effects interfering with daily performance: results from a cross-sectional cohort study of older psychiatric patients
Int. Psychogeriatr., 28 (2), 331-340
DOI 10.1017/S1041610215001544

Tveter AL, Bakken TL, Rossberg JI, Bech-Pedersen E, Bramness JG (2016)
Short communication: reliability and validity of the UKU Side Effect Rating Scale for adults with intellectual disabilities
Adv. Ment. Health Intellet. Disabil., 10 (3), 166-171
DOI 10.1108/AMHID-10-2015-0051

van Wel JHP, Gracia-Lor E, van Nuijs ALN, Kinyua J, Salvatore S, Castiglioni S, Bramness JG, Covaci A, Van Hal G (2016)
Investigation of agreement between wastewater-based epidemiology and survey data on alcohol and nicotine use in a community
Drug Alcohol Depend., 162, 170-175
DOI 10.1016/j.drugalcdep.2016.03.002

van Wel JHP, Kinyua J, van Nuijs ALN, Salvatore S, Bramness JG, Covaci A, Van Hal G (2016)
A comparison between wastewater-based drug data and an illicit drug use survey in a selected community
Int. J. Drug Policy, 34, 20-26
DOI 10.1016/j.drugpo.2016.04.003

Vindenes V, Bramness JG, Bretteville-Jensen AL, Morland J, Bachs L (2016)
Provides stronger cannabis have more health problems?
Tidsskr. Nor. Laegeforen., 136 (20), 1736-1738
DOI 10.4045/tidsskr.15.1297

Publications 2015

Bramness JG (2015)
Prevention and treatment of drug addictions An introduction
Tidsskr. Nor. Laegeforen., 135 (2), 155
DOI 10.4045/tidsskr.14.1294

Bramness JG (2015)
Cannabis as medicine
Tidsskr. Nor. Laegeforen., 135 (3), 252-253
DOI 10.4045/tidsskr.14.1426

Bramness JG (2015)
Handbook of cannabis
Tidsskr. Nor. Laegeforen., 135 (6), 577
DOI 10.4045/tidsskr.14.1511

Bramness JG (2015)
Patient Injury A thriller about the addictive drugs
Tidsskr. Nor. Laegeforen., 135 (19), 1768
DOI 10.4045/tidsskr.15.0787

Bramness JG, Henriksen B, Person O, Mann K (2015)
Bibliographic Searches for a Bibliometric Analysis on Drug Addiction Reply
Eur. Addict. Res., 21 (1), 32

Bramness JG, Reid MJ, Solvik KF, Vindenes V (2015)
Recent trends in the availability and use of amphetamine and methamphetamine in Norway
Forensic Sci.Int., 246, 92-97
DOI 10.1016/j.forsciint.2014.11.010

Bramness JG, Walby FA, Morken G, Roislien J (2015)
Analyzing Seasonal Variations in Suicide With Fourier Poisson Time-Series Regression: A Registry-Based Study From Norway, 1969-2007
Am. J. Epidemiol., 182 (3), 244-254
DOI 10.1093/aje/kwv064

Bramness JG, Walby FA, Morken G, Roislien J (2015)
RE: "ANALYZING SEASONAL VARIATIONS IN SUICIDE WITH FOURIER POISSON TIME-SERIES REGRESSION: A REGISTRY-BASED STUDY FROM NORWAY, 1969-2007" REPLY
Am. J. Epidemiol., 182 (9), 820-821
DOI 10.1093/aje/kwv210

Eikemo M, Bramness JG (2015)
Drugs, addiction, and the brain
Tidsskr. Nor. Laegeforen., 135 (9), 876
DOI 10.4045/tidsskr.15.0221

Martinez P, Neupane SP, Perlestenbakken B, Toutoungi C, Bramness JG (2015)
The association between alcohol use and depressive symptoms across socioeconomic status among 40-and 45-year-old Norwegian adults
BMC Public Health, 15, 1146
DOI 10.1186/s12889-015-2479-6

Medhus S, Rognli EB, Gossop M, Holm B, Morland J, Bramness JG (2015)
Amphetamine-Induced Psychosis: Transition to Schizophrenia and Mortality in a Small Prospective Sample
Am. J. Addict., 24 (7), 586-589
DOI 10.1111/ajad.12274

Nesvag R, Bramness JG, Ystrom E (2015)
The link between use of psychedelic drugs and mental health problems
J. Psychopharmacol., 29 (9), 1035-1036
DOI 10.1177/0269881115596156

Neupane SP, Lien L, Martinez P, Hestad K, Bramness JG (2015)
The Relationship of Alcohol Use Disorders and Depressive Symptoms to Tryptophan Metabolism: Cross-Sectional Data from a Nepalese Alcohol Treatment Sample
Alcoholism (NY), 39 (3), 514-521
DOI 10.1111/acer.12651

Neupane SP, Lien L, Ueland T, Mollnes TE, Aukrust P, Bramness JG (2015)
Serum brain-derived neurotrophic factor levels in relation to comorbid depression and cytokine levels in Nepalese men with alcohol-use disorders
Alcohol, 49 (5), 471-478
DOI 10.1016/j.alcohol.2015.01.012

Rognli EB, Berge J, Hakansson A, Bramness JG (2015)
Long-term risk factors for substance-induced and primary psychosis after release from prison. A longitudinal study of substance users
Schizophr. Res., 168 (1-2), 185-190
DOI 10.1016/j.schres.2015.08.032

Rognli EB, Medhus SE, Bramness JG (2015)
Amphetamine induced psychosis or schizophrenia?
Tidsskr. Nor. Laegeforen., 135 (3), 249-251
DOI 10.4045/tidsskr.14.1365

Rossow I, Bramness JG (2015)
The total sale of prescription drugs with an abuse potential predicts the number of excessive users: a national prescription database study
BMC Public Health, 15, 288
DOI 10.1186/s12889-015-1615-7

Salvatore S, Bramness JG, Reid MJ, Thomas KV, Harman C, Roislien J (2015)
Wastewater-Based Epidemiology of Stimulant Drugs: Functional Data Analysis Compared to Traditional Statistical Methods
PLoS One, 10 (9), e0138669
DOI 10.1371/journal.pone.0138669

Skrede S, Tvete IF, Tanum L, Steen VM, Bramness JG (2015)
Incident Users of Antipsychotic Agents and Future Use of Cholesterol-Lowering Drugs: An Observational, Pharmacoepidemiologic Study
J. Clin. Psychiatry, 76 (1), E111-E116
DOI 10.4088/JCP.14m08996

Publications 2014

Abel KF, Bramness JG, Martinsen EW (2014)
Stimulant Medication for ADHD in Opioid Maintenance Treatment
J. Dual Diagn., 10 (1), 32-38
DOI 10.1080/15504263.2013.867657

Bramness JG, Henriksen B, Person O, Mann K (2014)
A Bibliometric Analysis of European versus USA Research in the Field of Addiction. Research on Alcohol, Narcotics, Prescription Drug Abuse, Tobacco and Steroids 2001-2011
Eur. Addict. Res., 20 (1), 16-22
DOI 10.1159/000348260

Neupane SP, Bramness JG (2014)
Who seeks treatment for alcohol problems? Demography and alcohol-use characteristics of patients in taboo and non-taboo drinking groups attending professional alcohol services in Nepal
Asian J. Psychiatr., 12, 82-87
DOI 10.1016/j.ajp.2014.06.017

Neupane SP, Lien L, Martinez P, Aukrust P, Ueland T, Mollnes TE, Hestad K, Bramness JG (2014)
High Frequency and Intensity of Drinking may Attenuate Increased Inflammatory Cytokine Levels of Major Depression in Alcohol-use Disorders
CNS Neurosci. Ther., 20 (10), 898-904
DOI 10.1111/cns.12303

Rognli EB, Hakansson A, Berge J, Bramness JG (2014)
Does the pattern of amphetamine use prior to incarceration predict later psychosis?-A longitudinal study of amphetamine users in the Swedish criminal justice system
Drug Alcohol Depend., 143, 219-224
DOI 10.1016/j.drugalcdep.2014.07.037

Tveito M, Bramness J, Engedal K, Lorentzen B, Refsum H, Hoiseth G (2014)
Psychotropic medication in geriatric psychiatric patients: use and unreported use in relation to serum concentrations
Eur. J. Clin. Pharmacol., 70 (9), 1139-1145
DOI 10.1007/s00228-014-1720-z

Tveito M, Lorentzen B, Engedal K, Tanum L, Bramness JG, Refsum H, Hoiseth G (2014)
Changes in Cognitive Function during Psychogeriatric Treatment in Relation to Benzodiazepine Cessation
Pharmacopsychiatry, 47 (4-5), 145-150
DOI 10.1055/s-0034-1381982

Tveter AL, Bakken TL, Bramness JG, Rossberg JI (2014)
Adjustment of the UKU Side Effect Rating Scale for adults with intellectual disabilities. A pilot study
Adv. Ment. Health Intellet. Disabil., 8 (4), 260-267
DOI 10.1108/AMHID-11-2013-0064

Publications 2013

Bukten A, Herskedal A, Skurtveit S, Bramness JG, Clausen T (2013)
Driving under the influence (DUI) among patients in opioid maintenance treatment (OMT): a registry-based national cohort study
Addiction, 108 (11), 1954-1961
DOI 10.1111/add.12275

Gjersing L, Jonassen KV, Biong S, Ravndal E, Waal H, Bramness JG, Clausen T (2013)
Diversity in causes and characteristics of drug-induced deaths in an urban setting
Scand. J. Public Health, 41 (2), 119-125
DOI 10.1177/1403494812472007

Gundersen OH, Mordal J, Berman AH, Bramness JG (2013)
Evaluation of the Alcohol Use Disorders Identification Test and the Drug Use Disorders Identification Test among Patients at a Norwegian Psychiatric Emergency Ward
Eur. Addict. Res., 19 (5), 252-260
DOI 10.1159/000343485

Helseth V, Samet S, Johnsen J, Bramness JG, Waal H (2013)
Independent or Substance-Induced Mental Disorders? An Investigation of Comorbidity in an Acute Psychiatric Unit
J. Dual Diagn., 9 (1), 78-86
DOI 10.1080/15504263.2012.749142

Hoiseth G, Tanum L, Tveito M, Kristiansen KM, Kvande K, Lorentzen B, Refsum H, Bramness J (2013)
A Clinical Study of the Cognitive Effects of Benzodiazepines in Psychogeriatric Patients
Pharmacopsychiatry, 46 (6), 209-213
DOI 10.1055/s-0033-1349131

Holdo I, Handal M, Skurtveit S, Bramness JG (2013)
Association between prescribing hypnotics for parents and children in Norway
Arch. Dis. Child., 98 (9), 732-736
DOI 10.1136/archdischild-2013-303646

Medhus S, Holm B, Morland J, Bramness JG (2013)
Association Between Methamphetamine Versus Amphetamine and Acute Psychiatric Symptoms
J. Dual Diagn., 9 (4), 292-300
DOI 10.1080/15504263.2013.835161

Medhus S, Mordal J, Holm B, Morland J, Bramness JG (2013)
A comparison of symptoms and drug use between patients with methamphetamine associated psychoses and patients diagnosed with schizophrenia in two acute psychiatric wards
Psychiatry Res., 206 (1), 17-21
DOI 10.1016/j.psychres.2012.09.023

Mordal J, Medhus S, Holm B, Morland J, Bramness JG (2013)
Influence of Drugs of Abuse and Alcohol Upon Patients Admitted to Acute Psychiatric Wards Physician's Assessment Compared to Blood Drug Concentrations
J. Clin. Psychopharmacol., 33 (3), 415-419
DOI 10.1097/JCP.0b013e31828ec934

Neupane SP, Bramness JG (2013)
Prevalence and correlates of major depression among Nepalese patients in treatment for alcohol-use disorders
Drug Alcohol Rev., 32 (2), 170-177
DOI 10.1111/j.1465-3362.2012.00487.x

Neupane SP, Lien L, Hilberg T, Bramness JG (2013)
Vitamin D deficiency in alcohol-use disorders and its relationship to comorbid major depression: A cross-sectional study of inpatients in Nepal
Drug Alcohol Depend., 133 (2), 480-485
DOI 10.1016/j.drugalcdep.2013.07.006

Weibell MA, Joa I, Bramness J, Johannessen JO, McGorry PD, Hegelstad WT, Larsen TK (2013)
Treated incidence and baseline characteristics of substance induced psychosis in a Norwegian catchment area
BMC Psychiatry, 13, 319
DOI 10.1186/1471-244X-13-319

Publications 2012

Bramness JG (2012)
Commentary on Bosker et al. (2012): Driving under the influence of cannabinoids
Addiction, 107 (10), 1845-1846
DOI 10.1111/j.1360-0443.2012.03949.x

Bramness JG, Furu K, Skurtveit S, Engeland A (2012)
Effect of the Market Withdrawal of Carisoprodol on Use of Other Prescribed Drugs With Abuse Potential
Clin. Pharmacol. Ther., 91 (3), 438-441
DOI 10.1038/clpt.2011.250

Bramness JG, Gundersen OH, Guterstam J, Rognli EB, Konstenius M, Loberg EM, Medhus S, Tanum L, Franck J (2012)
Amphetamine-induced psychosis - a separate diagnostic entity or primary psychosis triggered in the vulnerable?
BMC Psychiatry, 12, 221
DOI 10.1186/1471-244X-12-221

Bramness JG, Skurtveit S, Morland J, Engeland A (2012)
An increased risk of motor vehicle accidents after prescription of methadone
Addiction, 107 (5), 967-972
DOI 10.1111/j.1360-0443.2011.03745.x

Hoiseth G, Majid U, Morland J, Bramness JG, Molden E (2012)
CYP2C19 genetics in fatal carisoprodol intoxications
Eur. J. Clin. Pharmacol., 68 (11), 1561-1565
DOI 10.1007/s00228-012-1278-6

von Soest T, Bramness JG, Pedersen W, Wichstrom L (2012)
The relationship between socio-economic status and antidepressant prescription: a longitudinal survey and register study of young adults
Epidemiol. Psychiatr. Sci., 21 (1), 87-95
DOI 10.1017/S2045796011000722

Publications 2011

Bramness JG, Clausen T, Duckert F, Ravndal E, Waal H (2011)
Addiction Research Centres and the Nurturing of Creativity The Norwegian Centre for Addiction Research (SERAF)
Addiction, 106 (8), 1381-1385
DOI 10.1111/j.1360-0443.2010.03086.x

Mordal J, Holm B, Gossop M, Romoren M, Morland J, Bramness JG (2011)
Psychoactive substance use among patients admitted to an acute psychiatric ward: Laboratory findings and associations with clinical characteristics
Nord. J. Psychiatr., 65 (3), 208-215
DOI 10.3109/08039488.2010.527014

Publications 2010

Bramness JG, Khiabani HZ, Morland J (2010)
Impairment due to cannabis and ethanol: clinical signs and additive effects
Addiction, 105 (6), 1080-1087
DOI 10.1111/j.1360-0443.2010.02911.x

Bramness JG, Rossow I (2010)
Can the total consumption of a medicinal drug be used as an indicator of excessive use? The case of carisoprodol
Drug-Educ. Prev. Policy, 17 (2), 168-180
DOI 10.3109/09687630903264278

Bramness JG, Sandvik P, Engeland A, Skurtveit S (2010)
Does Pregabalin (Lyrica (R)) Help Patients Reduce their Use of Benzodiazepines? A Comparison with Gabapentin using the Norwegian Prescription Database
Basic Clin. Pharmacol. Toxicol., 107 (5), 883-886
DOI 10.1111/j.1742-7843.2010.00590.x

Bramness JG, Walby FA (2010)
Internet use and suicide among younger age groups between 1989 and 2008 in Japan - Reply
Acta Psychiatr. Scand., 121 (6), 485-486
DOI 10.1111/j.1600-0447.2010.01548.x

Bramness JG, Walby FA, Hjellvik V, Selmer R, Tverdal A (2010)
Self-reported Mental Health and Its Gender Differences as a Predictor of Suicide in the Middle-Aged
Am. J. Epidemiol., 172 (2), 160-166
DOI 10.1093/aje/kwq091

Gjerde H, Mordal J, Christophersen AS, Bramness JG, Morland J (2010)
Comparison of Drug Concentrations in Blood and Oral Fluid Collected with the Intercept (R) Sampling Device
J. Anal. Toxicol., 34 (4), 204-209
DOI 10.1093/jat/34.4.204

Gjerden P, Slordal L, Bramness JG (2010)
Prescription persistence and safety of antipsychotic medication: a national registry-based 3-year follow-up
Eur. J. Clin. Pharmacol., 66 (9), 911-917
DOI 10.1007/s00228-010-0839-9

Lobmaier P, Gossop M, Waal H, Bramness J (2010)
The pharmacological treatment of opioid addiction-a clinical perspective
Eur. J. Clin. Pharmacol., 66 (6), 537-545
DOI 10.1007/s00228-010-0793-6

Mordal J, Gundersen O, Bramness JG (2010)
Norwegian version of the Mini-International Neuropsychiatric Interview: Feasibility, acceptability and test-retest reliability in an acute psychiatric ward
Eur. Psychiat., 25 (3), 172-177
DOI 10.1016/j.eurpsy.2009.02.004

Mordal J, Holm B, Morland J, Bramness JG (2010)
Recent Substance Intake Among Patients Admitted to Acute Psychiatric Wards Physician's Assessment and On-Site Urine Testing Compared With Comprehensive Laboratory Analyses
J. Clin. Psychopharmacol., 30 (4), 455-459
DOI 10.1097/JCP.0b013e3181e61923

Skurtveit S, Furu K, Bramness J, Selmer R, Tverdal A (2010)
Benzodiazepines Predict Use of Opioids-A Follow-Up Study of 17,074 Men and Women
Pain Med., 11 (6), 805-814
DOI 10.1111/j.1526-4637.2010.00870.x

Publications 2009

Bramness JG, Groholt B, Engeland A, Furu K (2009)
The use of lithium, valproate or lamotrigine for psychiatric conditions in children and adolescents in Norway 2004-2007-A prescription database study
J. Affect. Disord., 117 (3), 208-211
DOI 10.1016/j.jad.2009.01.006

Bramness JG, Skurtveit S, Neutel CI, Morland J, Engeland A (2009)
An increased risk of road traffic accidents after prescriptions of lithium or valproate?
Pharmacoepidemiol. Drug Saf., 18 (6), 492-496
DOI 10.1002/pds.1740

Bramness JG, Weitoft GR, Hallas J (2009)
Use of lithium in the adult populations of Denmark, Norway and Sweden
J. Affect. Disord., 118 (1-3), 224-228
DOI 10.1016/j.jad.2009.01.024

Gjerden P, Bramness JG, Slordal L (2009)
The use and potential abuse of anticholinergic antiparkinson drugs in Norway: a pharmacoepidemiological study
Br. J. Clin. Pharmacol., 67 (2), 228-233
DOI 10.1111/j.1365-2125.2008.03342.x

Gjerden P, Slordal L, Bramness JG (2009)
The use of antipsychotic and anticholinergic antiparkinson drugs in Norway after the withdrawal of orphenadrine
Br. J. Clin. Pharmacol., 68 (2), 238-242
DOI 10.1111/j.1365-2125.2009.03446.x

Gjerden P, Slordal L, Bramness JG (2009)
Association between the use of anticholinergic antiparkinson drugs and safety and receptor drug-binding profiles of antipsychotic agents
Eur. J. Clin. Pharmacol., 65 (12), 1229-1235
DOI 10.1007/s00228-009-0696-6

Gustavsen I, Al-Sammurraie M, Morland J, Bramness JG (2009)
Impairment related to blood drug concentrations of zopiclone and zolpidem compared to alcohol in apprehended drivers
Accid. Anal. Prev., 41 (3), 462-466
DOI 10.1016/j.aap.2009.01.011

Hausken A, Furu K, Skurtveit S, Engeland A, Bramness J (2009)
Starting insomnia treatment: the use of benzodiazepines versus z-hypnotics. A prescription database study of predictors
Eur. J. Clin. Pharmacol., 65 (3), 295-301
DOI 10.1007/s00228-008-0565-8

Hoiseth G, Karinen R, Sorlid HK, Bramness JG (2009)
The Effect of Scheduling and Withdrawal of Carisoprodol on Prevalence of Intoxications with the Drug
Basic Clin. Pharmacol. Toxicol., 105 (5), 345-349
DOI 10.1111/j.1742-7843.2009.00459.x

Skurtveit S, Strom H, Skrivarhaug T, Morland J, Bramness JG, Engeland A (2009)
Road traffic accident risk in patients with diabetes mellitus receiving blood glucose-lowering drugs. Prospective follow-up study
Diabetic Med., 26 (4), 404-408
DOI 10.1111/j.1464-5491.2009.02699.x

Publications 2008

Bramness JG, Skurtveit S (2008)
Carisoprodol Should be Taken Off the Market
South.Med.J., 101 (10), 1074-1075
DOI 10.1097/SMJ.0b013e318184ac60

Bramness JG, Skurtveit S, Gustavsen I, Morland J (2008)
The absence of evidence is not the same as evidence for absence!
Addiction, 103 (3), 513-514
DOI 10.1111/j.1360-0443.2007.02103.x

Bramness JG, Skuytveit S, Neutel CI, Morland J, Engeland A (2008)
Minor increase in risk of road traffic accidents after prescriptions of antidepressants: A study of population registry data in Norway
J. Clin. Psychiatry, 69 (7), 1099-1103
DOI 10.4088/JCP.v69n0709

Engeland A, Bramness JG, Daltveit AK, Ronning M, Skurtveit S, Furu K (2008)
Prescription drug use among fathers and mothers before and during pregnancy. A population-based cohort study of 106 000 pregnancies in Norway 2004-2006
Br. J. Clin. Pharmacol., 65 (5), 653-660
DOI 10.1111/j.1365-2125.2008.03102.x

Gjerden P, Bramness JG, Slordal L (2008)
Effect of warnings in a medical journal on the use of orphenadrine
J. Eval. Clin. Pract., 14 (4), 615-617
DOI 10.1111/j.1365-2753.2007.00912.x

Hoiseth G, Sorlid HK, Bramness J (2008)
Acute intoxications with carisoprodol
Clin. Toxicol., 46 (4), 307-309
DOI 10.1080/15563650701476953

Khiabani HZ, Morland J, Bramness JG (2008)
Frequency and irregularity of heart rate in drivers suspected of driving under the influence of cannabis
Eur. J. Intern. Med., 19 (8), 608-612
DOI 10.1016/j.ejim.2007.06.031

Mordal J, Bramness JG, Holm B, Morland J (2008)
Drugs of abuse among acute psychiatric and medical admissions: laboratory based identification of prevalence and drug influence
Gen. Hosp. Psych., 30 (1), 55-60
DOI 10.1016/j.genhosppsych.2007.10.006

Skurtveit S, Furu K, Bramness JG, Tverdal A (2008)
Benzodiazepine use in all alcohol consumers predicts use of opioids in patients 20 years later - a follow-up study of 13 390 men and women aged 40-42 years
Pharmacoepidemiol. Drug Saf., 17 (9), 926-933
DOI 10.1002/pds.1616

Publications 2007

Bramness JG, Furu K, Engeland A, Skurtveit S (2007)
Carisoprodol use and abuse in Norway. A pharmacoepidemiological study
Br. J. Clin. Pharmacol., 64 (2), 210-218
DOI 10.1111/j.1365-2125.2007.02847.x

Bramness JG, Kornor H (2007)
Benzodiazepine prescription for patients in opioid maintenance treatment in Norway
Drug Alcohol Depend., 90 (2-3), 203-209
DOI 10.1016/j.drugalcdep.2007.03.008

Bramness JG, Skurtveit S, Morland J, Engeland A (2007)
The risk of traffic accidents after prescriptions of carisoprodol
Accid. Anal. Prev., 39 (5), 1050-1055
DOI 10.1016/j.aap.2007.02.002

Bramness JG, Walby FA, Tverdal A (2007)
The sales of antidepressants and suicide rates in Norway and its counties 1980-2004
J. Affect. Disord., 102 (1-3), 1-9
DOI 10.1016/j.jad.2006.12.002

Hausken AM, Skurtveit S, Rosvold EO, Bramness JG, Furu K (2007)
Psychotropic drug use among persons with mental distress symptoms: A population-based study in Norway
Scand. J. Public Health, 35 (4), 356-364
DOI 10.1080/14034940601159161

Publications 2006

Bramness JG, Skurtveit S, Morland J (2006)
Flunitrazepam: Psychomotor impairment, agitation and paradoxical reactions
Forensic Sci.Int., 159 (2-3), 83-91
DOI 10.1016/j.forsciint.2005.06.009

Publications 2001

Bachs LC, Bramness JG, Waal H (2001)
Buprenorfin i legemiddelassistert rehabilitering: hva vet vi i dag?
Statens rettstoksikologiske institutt, Oslo, [42] s.
BIBSYS 012276391, ISBN 82-91049-33-5

Publications 2000

Bachs LC, Bramness JG, Waal H (2000)
Buprenorfin: en litteraturgjennomgang
MARIO, Oslo, [23] bl.
BIBSYS 001486209